Physician profile
Thomas Arthur Devine
NPI 1548627516
$380.94
in general payments reported to CMS, 2019-2025
10 companies · $113 in 2025
The $113 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $103 · 2023: $146 · 2024: $19.78 · 2025: $113.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $278.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $278.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $91.85 | 2022-2023 | |
| Novo Nordisk INC | $60.60 | 2022-2025 | Ozempic, Rybelsus |
| Organon LLC | $44.45 | 2023 | Nexplanon |
| Otsuka Pharmaceutical Development & Commercialization, INC. | $44.23 | 2025 | Rexulti |
| Dexcom, INC. | $40.20 | 2024-2025 | Dexcom G6 Transmitter |
| Abbott Laboratories | $24.83 | 2025 | Freestyle Libre 3 |
| Biohaven Pharmaceutical Holding Company Ltd. | $23.16 | 2022 | |
| Glaxosmithkline, LLC. | $19.76 | 2023 | Bexsero, Shingrix |
| Sanofi Pasteur INC. | $19.50 | 2023 | |
| Medtronic, INC. | $12.36 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Devine listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.